Medacta Group SA Financials

Market Capitalization CHF2.69 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	39.82
Forward PE	34.04
Price to Sales TTM	CHF4.58
Price to Book MRQ	CHF7.12
Enterprise to Revenue	4.89
Enterprise to EBITDA	20.29

Financial Reports as of Dec. 31, 2024

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2024-12-31
Profit Margin	12.34%
Operating Margin	15.70%
Return on Assets TTM	7.81%
Return on Equity TTM	20.54%

Income Statement

Revenue TTM	CHF551,188,295
Revenue per Share TTM	CHF29.65
Quarterly Revenue Growth	18.10%
Gross Profit TTM	CHF372,796,434
EBITDA	CHF163,818,000
Net Income to Common TTM	CHF68,024,505
Diluted EPS TTM	CHF3.41
Quarterly Earnings Growth YoY	91.50%

Balance Sheet

Total Cash MRQ	CHF29,481,081
Total Cash per Share MRQ	CHF1.59
Total Debt MRQ	CHF
Total Debt to Equity MRQ	64.23
Current Ratio MRQ	2.51
Book Value per Share MRQ	CHF19.06

Cash Flow

Operating Cash Flow TTM	CHF99,994,697
Levered Free Cash Flow TTM	CHF-14,795,955

MOVE Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	19,919,282
Float Shares	5,994,310
Avg 10 Volume	7,450
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	69.63%
% Held by Institutions	17.92%

Stock Price Summary

Beta	1.12
Fifty Two Week Low	CHF103.60
Fifty Two Week High	CHF143.80
Fifty Two Week Change	9.82%
Day 50 MA	CHF135.34
Day 200 MA	CHF123.35

Dividends and Splits

Forward Annual Dividend Rate	CHF2.76
Forward Annual Dividend Yield	2.06%
Trailing Annual Dividend Rate	CHF0.69
Trailing Annual Dividend Yield	0.52%
Payout Ratio	15.40%
Dividend Date	2025-05-13
Ex Dividend Date	2025-05-09
Last Split Factor
Last Split Date